Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Brain Communications|May 24, 2024
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's diseaseLeonardo Iaccarino, Jorge J Llibre-Guerra, Eric McDade, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
The Journal of Prevention of Alzheimer'S Disease|January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degenerationJesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementiaJuan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, et al.
Neurology|July 5, 2022
Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar DegenerationPhilip Wade Tipton, Angela B Deutschlaender, Rodolfo Savica, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Brain Communications|May 24, 2024
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's diseaseLeonardo Iaccarino, Jorge J Llibre-Guerra, Eric McDade, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
The Journal of Prevention of Alzheimer'S Disease|January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degenerationJesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementiaJuan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, et al.
Neurology|July 5, 2022
Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar DegenerationPhilip Wade Tipton, Angela B Deutschlaender, Rodolfo Savica, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2025
Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differencesIsis So, Arabella Bouzigues, Lucy L Russell, et al.
Brain : a Journal of Neurology|October 21, 2017
Clinicopathological correlations in behavioural variant frontotemporal dementiaDavid C Perry, Jesse A Brown, Katherine L Possin, et al.
Pageof 33